Previous studies have reported an effective role of GSTP1 rs1695 in terms of the clinical outcome of breast cancer patients36 and a significant association between high GSTP1 expression of tumor cells and reduced sensitivity to chemotherapy37, 38. The gene discussed is GSTP1; the disease is breast carcinoma.